phosphatidylethanol drug

Aliases

PEth

External links

DrugBank · PubChem

Related entities (16)

Mentioned in (29)

Papers in which this entity is mentioned.

• Safe start, a hybrid intervention to reduce alcohol exposed pregnancies: protocol for a randomized controlled trial. (2026)
• Untargeted and Targeted Blood Lipidomic Signature Profile of Gestational Alcohol Exposure. (2023)
• Predicting Fetal Alcohol Spectrum Disorders Using Machine Learning Techniques: Multisite Retrospective Cohort Study. (2023)
• Prenatal alcohol exposure can be determined from baby teeth: Proof of concept. (2022)
• Untargeted Metabolome Analysis Reveals Reductions in Maternal Hepatic Glucose and Amino Acid Content That Correlate with Fetal Organ Weights in a Mouse Model of Fetal Alcohol Spectrum Disorders. (2022)
• Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysis. (2021)
• Computer-based alcohol reduction intervention for alcohol-using HIV/HCV co-infected Russian women in clinical care: study protocol for a randomized controlled trial. (2021)
• Infant circulating MicroRNAs as biomarkers of effect in fetal alcohol spectrum disorders. (2021)
• An enriched biosignature of gut microbiota-dependent metabolites characterizes maternal plasma in a mouse model of fetal alcohol spectrum disorder. (2021)
• Murine Models for the Study of Fetal Alcohol Spectrum Disorders: An Overview. (2020)
• Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations. (2019)
• Elimination Characteristics of the Alcohol Biomarker Phosphatidylethanol (PEth) in Blood during Alcohol Detoxification. (2019)
• Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected. (2018)
• A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: Past issues and future directions. (2018)
• The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice. (2016)
• Lipids and Oxidative Stress Associated with Ethanol-Induced Neurological Damage. (2016)
• Alcohol Use During Pregnancy is Associated with Specific Alterations in MicroRNA Levels in Maternal Serum. (2016)
• Prenatal Alcohol Exposure and the Developing Immune System. (2015)
• Advances in Diagnosis and Treatment of Fetal Alcohol Spectrum Disorders: From Animal Models to Human Studies. (2015)
• Improving Recognition of Children Affected by Prenatal Alcohol Exposure: Detection of Exposure in Pediatric Care. (2015)
• Maternal and neonatal plasma microRNA biomarkers for fetal alcohol exposure in an ovine model. (2014)
• A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis. (2014)
• The validity of phosphatidylethanol in dried blood spots of newborns for the identification of prenatal alcohol exposure. (2014)
• The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots. (2013)
• Perinatal exposure to alcohol: implications for lung development and disease. (2013)
• Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. (2012)
• Candidate placental biomarkers for intrauterine alcohol exposure. (2011)
• Focus on: biomarkers of fetal alcohol exposure and fetal alcohol effects. (2011)
• Modeling alcohol's effects on organs in animal models. (2000)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.